Education
About Us
Working with TipRanks
Follow Us
OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.12Last Year’s EPS
-0.11Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 12, 2025
|% Change Since: 109.18%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with several achievements, such as surpassing revenue expectations and expanding margins, alongside successful cost-cutting initiatives. However, there was a slight decline in cash reserves and ongoing debt obligations. Overall, the highlights significantly outweigh the lowlights.Company Guidance
During the OptimizeRx Fourth Quarter and Full Year Fiscal 2024 Earnings Conference Call, CEO Steve Silvestro expressed optimism about the company's growth and transformation under his leadership. He announced that the company's revenue and adjusted EBITDA for fiscal 2024 surpassed guidance and street expectations, coming in at $92.1 million and $11.7 million, respectively. The fourth quarter revenue was $32.3 million, a 14% increase compared to the same period in 2023, driven by increased DAAP-related revenue streams. The company's gross margin for the quarter rose to 68.2% from 62.9% a year ago, attributed to a favorable solution and channel partner mix. The operating expenses for Q4 decreased by $10.4 million year-over-year due to lower M&A-related costs and cost-cutting initiatives. The company aims to become a Rule of 40 company over the next three to five years by driving top-line growth and expanding EBITDA. The focus will be on customer centricity, expanding DAAP deals, and transitioning to a subscription-based model for data services to enhance revenue predictability and margins. The company witnessed strong momentum in DAAP deals, with a 100% year-over-year increase and an improved net revenue retention rate of 121%, up from 105% in the prior year.Exceeded Guidance and Street Expectations
OptimizeRx reported revenue of $92.1 million and an adjusted EBITDA of $11.7 million for Fiscal Year 2024, surpassing both guidance and Street expectations.
Strong Revenue and Margin Growth
Fourth quarter revenue increased by 14% to $32.3 million compared to the same period in 2023. Gross margin expanded to 68.2% from 62.9% year-over-year.
Significant Cost Savings
Operating expenses decreased by $10.4 million year-over-year, with cost-cutting initiatives saving approximately $5 million annually.
High Net Revenue Retention
The net revenue retention rate improved to 121%, up from 105% in the previous year.
---
OPRX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
OPRX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 12, 2025 | $4.14 | $6.28 | +51.69% |
| Nov 13, 2024 | $6.15 | $4.06 | -33.98% |
| Aug 08, 2024 | $8.85 | $8.38 | -5.31% |
| May 14, 2024 | $10.48 | $13.17 | +25.67% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does OptimizeRx Corporation (OPRX) report earnings?
OptimizeRx Corporation (OPRX) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is OptimizeRx Corporation (OPRX) earnings time?
OptimizeRx Corporation (OPRX) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OPRX EPS forecast?
OPRX EPS forecast for the fiscal quarter 2025 (Q1) is -0.12.
---